Clinical Trial

Trastuzumab Deruxtecan in Advanced Breast Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of trastuzumab deruxtecan in advanced breast cancer patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2025-11-16
Trial Details
NCT Number NCT07180264
Lead Sponsor Wenjin Yin
Conditions Advanced Breast Cancer
Enrollment 118 participants
Start Date 2025-08-28
Primary Completion 2027-02 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2025-11-18